Fluicell is a renowned biotech company that was founded in 2012 as a spin-off from Chalmers University of Technology in Sweden. Specializing in high resolution bioprinting and single-cell biology, Fluicell is a global leader and pioneer in open-volume microfluidics for the life sciences. With a strong IP and patent position, the company offers a wide range of innovative products and services.

Their product portfolio includes the 3D single-cell bioprinting platforms Biopixlar and Biopixlar AER, as well as the BioPen, Biozone 6, and Dynaflow Resolve series for single-cell biological and pharmacological research. These cutting-edge technologies empower researchers to explore new frontiers in regenerative medicine and advance their understanding of single-cell biology. Fluicell's team of specialists is available to provide expert support and guidance to customers, ensuring they maximize the potential of their products.

Offering exceptional customer service, Fluicell is dedicated to responding to inquiries within 24 hours. Headquartered in Mölndal, Sweden, Fluicell complies with GDPR regulations and can be contacted via phone or email. Their trademarks include Fluicell®, Biopen®, Biozone 6®, Biopixlar®, and Lab-on-a-tip®.

Explore the possibilities with Fluicell and revolutionize your research in the life sciences